Thirty-six persons found to be healthy HBsAg carriers by routine donor screening from 1970 to 1973 were offered a follow-up examination in 1978. A total of 21 out of the 34 still living carriers were reexamined clinically, serologically, and biochemically. Seventeen of the 20 still HBsAg-positive carriers had anti-HBe, and 2 were HBeAg-positive. Liver biopsy in these two carriers showed chronic persistent hepatitis. No biochemical abnormalities were found in any but one who was HBeAg-positive and one who was negative for both HBeAg and anti-HBe. Anti-HBc titers varied between 1:3,600 and 1:83,000. Circulating immune complexes were demonstrated in 30% of the healthy HBsAg carriers. On the basis of 5-8 years' follow-up it is concluded that the healthy HBsAg carrier state is a benign condition that has not affected the carrier's quality of life. Progression to a severe, chronic liver disease was not observed in any of the healthy carriers. The importance and nature of circulating immune complexes in healthy HBsAg carriers was unknown and need further investigation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/00365528109181032 | DOI Listing |
Hepatol Commun
February 2025
University Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble, France.
Background: Hepatitis B is a liver infection caused by HBV. Infected individuals who fail to control the viral infection develop chronic hepatitis B and are at risk of developing life-threatening liver diseases, such as cirrhosis or liver cancer. Dendritic cells (DCs) play important roles in the immune response against HBV but are functionally impaired in patients with chronic hepatitis B.
View Article and Find Full Text PDFWorld J Gastroenterol
January 2025
Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China.
Background: C-X-C chemokine receptor type 5 (CXCR5)CD8 T cells represent a unique immune subset with dual roles, functioning as cytotoxic cells in persistent viral infections while promoting B cell responses. Despite their importance, the specific role of CXCR5CD8 T cells in chronic hepatitis B (CHB), particularly during interferon-alpha (IFN-α) treatment, is not fully understood. This study aims to elucidate the relationship between CXCR5CD8 T cells and sustained serologic response (SR) in patients undergoing 48 weeks of pegylated IFN-α (peg-IFN-α) treatment for CHB.
View Article and Find Full Text PDFAnn Med
December 2025
Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Background: Numerous meta-analyses have identified various risk factors for hepatocellular carcinoma (HCC), prompting a comprehensive study to synthesize evidence quality and strength.
Methods: This umbrella review of meta-analyses was conducted throughout PubMed, EMBASE, Web of Science, and Cochrane Database of Systematic Reviews. Evidence strength was evaluated according to the evidence categories criteria.
Alpha Psychiatry
November 2024
Department of Psychiatry, Freelance Physician, İstanbul, Türkiye.
Objective: The psychiatric disorders among healthy carriers of hepatitis B (HBsAg), who have no severe physical disability or any medical treatment, have clinical importance. We aimed to research the comorbid psychiatric disorders and alexithymia and to identify whether alexithymia and accompanying somatic symptoms predict the presence of psychiatric diagnoses or not among HBsAg carriers.
Methods Eighty-nine: healthy carriers of Hepatitis B patients and nınety-three healthy individuals were included to study.
Lancet Microbe
December 2024
Jenner Institute, University of Oxford-NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address:
Background: Malaria remains a substantial public health burden among young children in sub-Saharan Africa and a highly efficacious vaccine eliciting a durable immune response would be a useful tool for controlling malaria. R21 is a malaria vaccine comprising nanoparticles, formed from a circumsporozoite protein and hepatitis B surface antigen (HBsAg) fusion protein, without any unfused HBsAg, and is administered with the saponin-based Matrix-M adjuvant. This study aimed to assess the safety and immunogenicity of the malaria vaccine candidate, R21, administered with or without adjuvant Matrix-M in adults naïve to malaria infection and in healthy adults from malaria endemic areas.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!